DGX

Quest Diagnostics Inc · Health Care

$229.95▼ $1.14 (0.49%) todayMarket open

Price

Live from the market

▼ $10.85 (-4.51%) past month

Key Statistics

This session and the business

  • Open$230.58
  • High$230.68
  • Low$228.94
  • Previous close$231.09
  • Volume279,554
  • Market cap$25.51B
  • Price to earnings24.11
  • Earnings per share$9.44
  • 52 week range$171.18 to $248.84
  • Beta0.56
  • Dividend yield2.10%

The Desk and DGX

What this desk has done with it

The desk has not traded DGX yet. Suggest it on the Live Desk.

The Numbers

As reported to the SEC

RevenueNet income
 FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$9.44B$10.79B$9.88B$9.25B$9.87B$11.04B
Gross profit$3.63B$4.21B$3.43B$3.05B$3.24B$3.67B
Operating income$1.97B$2.38B$1.43B$1.26B$1.35B$1.56B
Net income$1.43B$2.00B$946.0M$854.0M$871.0M$992.0M
EPS (diluted)$10.47$15.55$7.97$7.49$7.69$8.75

Earnings

Reported per quarter

Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26

Reported earnings per share, last 8 quarters.

Over the Years

Valuation and margin

YearP/ENet MarginROE
202519.89.5%14.8%
202419.69.3%13.8%
202318.49.8%14.6%
202219.610.3%16.2%
202111.119.3%30.9%
202011.415.9%23.7%

What Analysts Say

23 covering, 2026-09-01

  • Buy13
  • Hold10
  • Sell0

Earnings Calls

Read what was said

Insider Moves

Filed with the SEC

  • Michael E. PrevoznikSVP & General Counselbought 22,677 shares2026-08-28
  • Michael E. PrevoznikSVP & General Counselsold 22,677 shares2026-08-28
  • Delaney Mark ESVP & Chief Commercial Officersold 1,600 shares2026-07-28
  • Plewman PatrickSVP for Diagnostic Servicesbought 46 shares2026-07-22
  • Wright Lassiter IIIDirectorbought 6 shares2026-07-22
  • Timothy L. MainDirectorbought 21 shares2026-07-22
  • Sam A. SamadExecutive Vice President & CFObought 102 shares2026-07-22
  • Michael E. PrevoznikSVP & General Counselsold 1,000 shares2026-08-28

Filings

Straight from EDGAR